Patent · US Active

Cytotoxic agents comprising new tomaymycin derivatives

US8163736B2 · kind B2 · utility

137Cited by
6References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 16, 2008
Grant dateApr 24, 2012
Priority date
Expiry dateJan 9, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is related to new tomaymycin derivatives, their process of preparation and their therapeutic uses.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.